CEPI fastbacks three candidate vaccines for Ebola BDV. Two virus vector based candidates and one mRNA vaccine candidate.
Once again it's taken a raging outbreak of a pathogen identified over two decades ago for vaccine development to be accelerated.
cepi.net/cepi-fast-tr...
CEPI funding will advance vaccine candidates towards clinical trials as quickly as possible.
